Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 23.63B | 23.63B | 20.71B | 20.35B | 19.04B | 16.97B |
Gross Profit | 8.01B | 8.01B | 6.68B | 6.27B | 6.27B | 5.56B |
EBITDA | 3.95B | 3.95B | 3.14B | 2.96B | 3.29B | 2.62B |
Net Income | 2.47B | 2.47B | 1.91B | 1.68B | 2.05B | 1.50B |
Balance Sheet | ||||||
Total Assets | 27.00B | 27.00B | 27.92B | 26.51B | 25.88B | 24.94B |
Cash, Cash Equivalents and Short-Term Investments | 7.92B | 7.92B | 6.54B | 5.93B | 5.54B | 5.32B |
Total Debt | 17.27M | 17.27M | 21.37M | 23.94M | 26.99M | 20.00M |
Total Liabilities | 5.10B | 5.10B | 4.81B | 4.61B | 4.39B | 4.41B |
Stockholders Equity | 21.90B | 21.90B | 23.11B | 21.90B | 21.49B | 20.53B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.20B | 1.13B | 538.07M | 1.55B | 1.84B |
Operating Cash Flow | 0.00 | 3.59B | 1.84B | 947.42M | 1.79B | 2.41B |
Investing Cash Flow | 0.00 | 182.80M | -281.44M | 716.59M | -604.65M | -1.46B |
Financing Cash Flow | 0.00 | -3.68B | -883.04M | -1.18B | -862.55M | -355.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥36.73B | 10.55 | 11.23% | 2.94% | 5.16% | 32.19% | |
76 Outperform | ¥29.05B | 14.13 | 4.12% | 2.94% | 5.29% | 1.50% | |
74 Outperform | ¥32.61B | 12.90 | 6.86% | 2.62% | 0.81% | 2.21% | |
72 Outperform | ¥30.03B | 12.59 | ― | 2.03% | 5.92% | 11.71% | |
71 Outperform | ¥28.91B | 13.49 | 4.21% | 2.68% | -6.65% | -45.46% | |
69 Neutral | ¥60.59B | 19.24 | 6.67% | 1.76% | 11.99% | 31.00% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Ishihara Chemical Co., Ltd. has completed the payment procedure for the disposal of 8,100 common shares as restricted stock compensation. This strategic move, involving a total value of 16,710,300 yen, is aimed at compensating six directors of the company, excluding audit and supervisory committee members and outside directors.
Ishihara Chemical Co., Ltd. has announced the disposal of 8,100 treasury shares as restricted stock compensation for its directors, excluding outside directors. This move is part of a broader plan to incentivize directors and align their interests with shareholders, promoting sustainable growth in corporate value. The shares will be allocated to six directors, with restrictions on transfer until certain conditions are met, such as the director’s continued service or organizational restructuring. This initiative reflects the company’s strategic focus on enhancing governance and stakeholder alignment.
Ishihara Chemical Co., Ltd. reported a decline in its consolidated financial results for the three months ended June 30, 2025, with net sales, operating profit, and profit attributable to owners of the parent all decreasing compared to the same period last year. Despite this, the company maintains a strong capital adequacy ratio and has announced a slight increase in its annual dividends forecast for the fiscal year ending March 31, 2026, indicating a cautious optimism about future performance.